SHPRH-146aa is downregulated in GBM compared with para-cancerous tissues and overexpression of SHPRH-146aa significantly inhibited glioma growth in xenograft mouse models (Zhang M. et al., 2018; Table 1). Here, SHPRH is linked to central nervous system cancer.